76 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
to find these provisions of our governance documents inapplicable to, or unenforceable in respect of, one or more of the specified types of actions … , and other expenses associated with public company reporting requirements. We also incur costs associated with corporate governance requirements
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
. Alternatively, if a court were to find these provisions of our governance documents inapplicable to, or unenforceable in respect of, one or more … governance requirements, including requirements under the Sarbanes-Oxley Act, as well as rules implemented by the SEC and Nasdaq. These rules and regulations
POS AM
apa3rrhla9
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
424B3
sjzzq 0h8jvo
6 Feb 24
Prospectus supplement
9:37pm
8-K
EX-3.1
749q6qwm5i3j eoqn
5 Feb 24
Entry into a Material Definitive Agreement
7:36am
8-K
e8c13d1ktt sdap46h
5 Feb 24
Entry into a Material Definitive Agreement
7:36am
8-K
7gl1 xn5a8s
18 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm
424B3
0lqi342o
30 Nov 23
Prospectus supplement
5:18pm
8-K
kx5 gai5jhq
28 Nov 23
Appoints CEO and Additional Directors, and Expands Leadership Team to
7:33am